Quantification of Longitudinal Patient-Reported Burden of Adverse Drug Reactions Attributed to the Use of TNF-α Inhibitors in inflammatory rheumatic diseases: an observational prospective cohort study.

Benthe H KönigHelen R GosseltJette A van LintLeanne J KosseBart J F Ten KloosterPeter M van den BemtHarald E VonkemanNaomi T Jessurun

Published in: Expert opinion on drug safety (2024)

Patient-reported burden of ADRs attributed to the use of a TNF-α inhibitor in patients with IRDs decreased significantly over time, especially for infections and infestations.

Keyphrases

patient reported
adverse drug
rheumatoid arthritis
cross sectional
electronic health record
emergency department